These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18568705)

  • 1. Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.
    Poole NA; Agrawal N
    Brain Inj; 2008 Jul; 22(7-8):519-34. PubMed ID: 18568705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of traumatic brain injury: learning from experience.
    Ruff RL; Riechers RG
    JAMA; 2012 Nov; 308(19):2032-3. PubMed ID: 23168827
    [No Abstract]   [Full Text] [Related]  

  • 3. Donepezil for cognitive deficits following traumatic brain injury: a case report.
    Bourgeois JA; Bahadur N; Minjares S
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):463-4. PubMed ID: 12426418
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new treatment for hypoxic brain injury?
    Flood P
    Anesth Analg; 2007 Sep; 105(3):559-60. PubMed ID: 17717206
    [No Abstract]   [Full Text] [Related]  

  • 6. [Donepezil therapy in patients with vascular and post-traumatic cognitive impairment: some clinical observations].
    Olazarán-Rodríguez J; Cruz-Orduña I; Jiménez-Martín I
    Rev Neurol; 2004 May 16-31; 38(10):938-43. PubMed ID: 15175977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
    Bekker A; Haile M; Gingrich K; Wenning L; Gorny A; Quartermain D; Blanck T
    Anesth Analg; 2007 Sep; 105(3):739-43. PubMed ID: 17717233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of donepezil for cognitive rehabilitation after traumatic brain injury: a systematic review.
    Ballesteros J; Güemes I; Ibarra N; Quemada JI
    J Head Trauma Rehabil; 2008; 23(3):171-80. PubMed ID: 18520431
    [No Abstract]   [Full Text] [Related]  

  • 9. Citicoline, use in cognitive decline: vascular and degenerative.
    García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
    J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of acetylcholinesterase inhibitors on cognitive function in patients with chronic traumatic brain injury: A systematic review.
    Bengtsson M; Godbolt AK
    J Rehabil Med; 2016 Jan; 48(1):1-5. PubMed ID: 26660510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
    Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
    Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment: potential pharmacological treatment options.
    Sherwin BB
    J Am Geriatr Soc; 2000 Apr; 48(4):431-41. PubMed ID: 10798472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
    Blacker D
    N Engl J Med; 2005 Jun; 352(23):2439-41. PubMed ID: 15829528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.